Győrffy B et al: Research funding: past performance is a stronger predictor of future scientific output than reviewer scores Journal of Informetrics (2020)

Győrffy B et al. Is there a Golden Age in publication activity? – an analysis of age-related scholarly performance across all scientific disciplines Scientometrics (2020)

Menyhárt O and Győrffy B: Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches, Cancer and Metastasis Reviews (2020)

Fan J-B, Győrffy B, et al: Type I Interferon Regulates a Coordinated Gene Network to Enhance Cytotoxic T Cell-Mediated Tumor Killing, Cancer Discovery (2020)

Fekete J et al: Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1,816 ovarian cancer patients, Gynecologic Oncology (2020)

We have released a new analysis platform to link mutation and gene expression changes - click on image to visit site.

Nagy A et al.: Elevated HOX gene expression in acute myeloid leukemia is associated with NPM1 mutations and poor survival. J Advanced Research (2019)

Menyhárt O et al.: Uncovering Potential Therapeutic Targets in Colorectal Cancer by Deciphering Mutational Status and Expression of Druggable Oncogenes, Cancers (2019)

Perone Y, Győrffy B, Magnani L et al: SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer. Nature Communications (2019)

Fekete J and Győrffy B: ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients, International Journal of Cancer (2019)